Preimplantation genetic diagnosis for myotonic dystrophy type 1 in the UK

2008 ◽  
Vol 18 (2) ◽  
pp. 131-136 ◽  
Author(s):  
Georgia Kakourou ◽  
Seema Dhanjal ◽  
Thalia Mamas ◽  
Sarah Gotts ◽  
Alpesh Doshi ◽  
...  
2009 ◽  
Vol 17 (11) ◽  
pp. 1403-1410 ◽  
Author(s):  
Marjan De Rademaeker ◽  
Willem Verpoest ◽  
Martine De Rycke ◽  
Sara Seneca ◽  
Karen Sermon ◽  
...  

2016 ◽  
Vol 76 (10) ◽  
Author(s):  
A Hehr ◽  
B Seifert ◽  
C Gaßner ◽  
B Paulmann ◽  
D Seifert ◽  
...  

2007 ◽  
Vol 27 (2) ◽  
pp. 111-116 ◽  
Author(s):  
Georgia Kakourou ◽  
Seema Dhanjal ◽  
Danny Daphnis ◽  
Alpesh Doshi ◽  
Sarah Nuttall ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-7 ◽  
Author(s):  
Raquel María Fernández ◽  
María Dolores Lozano-Arana ◽  
Beatriz Sánchez ◽  
Ana Peciña ◽  
Juan Carlos García-Lozano ◽  
...  

Myotonic dystrophy type 1 (DM1) is the most common adult muscular dystrophy and presents an autosomal dominant inheritance. A reproductive option for the families affected is preimplantation genetic diagnosis (PGD). One limitation of this option is the nonoptimal response to ovarian stimulation of the women with DM1, although controversial results exist regarding this subject. In this study, we have analyzed the results of the PGD program applied to DM1 at our institution. A total of 35 couples have been included in our program since 2010, and 59 cycles have been performed. The percentage of transfers per cycle was 64.4% and the live birth rate per cycle was 18.6%. Interestingly, statistically significant differences were observed for the clinical results in the group of couples with an affected female versus the group with an affected male or versus a group of couples with different referral reasons. Specifically, both the percentage of mature oocytes out of the total oocytes retrieved and the percentage of fertilization were considerably lower in the group of DM1 females. Our findings would suggest the possibility of achieving less favourable PGD outcomes in women with DM1 in comparison with other pathologies, although the underlying mechanism remains unknown.


2020 ◽  
Vol 267 (11) ◽  
pp. 3235-3242
Author(s):  
Erik Landfeldt ◽  
Nikoletta Nikolenko ◽  
Cecilia Jimenez-Moreno ◽  
Sarah Cumming ◽  
Darren G. Monckton ◽  
...  

Abstract Objective The objective of this longitudinal, observational study was to investigate change over time in ability to perform activities of daily living in myotonic dystrophy type 1 (DM1). Methods Adults with genetically confirmed DM1 were recruited as part of the PhenoDM1 study in the UK. Data on activities of daily living were recorded through the DM1-ActivC at baseline and a follow-up visit after 12 (± 3) months. A subset of patients had advanced genetic testing to determine the size of the progenitor allele. Results Our sample comprised 150 patients with DM1 (mean age: 45 years; 52% female). Mean follow-up was 383 days. Mean DM1-ActivC total score at baseline was 71.24 (95% confidence interval 67.77–74.71) and at the follow-up visit 69.04 (65.54–72.54). Approximately 43% of patients had a lower score at the follow-up visit (indicating a decreased ability to perform activities of daily living), 24% a higher score (indicating an increased ability), and 33% the same score at baseline and follow-up. The mean annual change in the DM1-ActivC total score, estimated at − 2.06 (− 3.54 to − 0.59), was significantly related to patients’ baseline score, but not sex, disease duration, timed test results, or cytosine-thymine-guanine repeat length. Conclusions Change over time in ability to perform activities of daily living as recorded through the DM1-ActivC varies substantially between patients with DM1. Our data contribute to the understanding of the natural evolution of the disease, and should be helpful to inform the design of future trials based on the DM1-ActivC.


2018 ◽  
Vol 97 (1) ◽  
pp. 78-81
Author(s):  
E.A. Mamaeva ◽  
◽  
L.A. Fedorova ◽  
S.E. Voronovich ◽  
V.D. Nazarov ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document